Physician profile
Lori Lynn Kellogg
NPI 1629185871
$259.28
in general payments reported to CMS, 2019-2025
12 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $34.45 · 2023: $40.39 · 2024: $36.07 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $40.01 | 2025 | Veozah |
| Aspira Women'S Health INC | $34.45 | 2021 | |
| Organon LLC | $23.91 | 2025 | Nexplanon |
| Hologic Sales and Service, LLC | $22.12 | 2024 | Aptima |
| Novo Nordisk INC | $20.41 | 2023 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $19.98 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $19.46 | 2025 | Exparel |
| Merck Sharp & Dohme LLC | $19.17 | 2025 | Gardasil 9 |
| Ethicon US, LLC | $15.79 | 2025 | Ethicon, Evarrest, Stratafix |
| Terumo Medical Corporation | $15.60 | 2025 | Azur Cx Detachable |
| Biogen, INC. | $14.43 | 2025 | Zurzuvae |
| Pfizer INC. | $13.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Kellogg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.